Last chance to take part in AusBiotech’s annual CEO survey
Tuesday, 31 January, 2012
Proudly supported by Grant Thornton, the survey is seeking views on the operating environment and asks questions that will help build evidence about the significance of the industry and its perspectives, as well as tracking trends.
The de-identified results will be released in a comprehensive industry report, to be launched at industry briefings in April. Last year 42 of Australia’s biotechnology companies were named as participants in the report and a further group contributed anonymously.
The information in report was of interest to government representatives, parliamentarians, the media and investors, as well as to the industry itself.
In order for AusBiotech to rally as a cohesive industry body with a common goal, it seeks this information to build a strong platform for campaigning, to better represent the sector with strong statements about the magnitude of issues and trends and what would be likely to redress them.
Enquires about the survey may be directed to AusBiotech’s Communications Manager on lchiroiu@ausbiotech.org or 03 9828 1414.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
